Stereotaxis (STXS) Cash from Investing Activities Growth (3y) (2014 - 2026)
Stereotaxis (STXS) Cash from Investing Activities Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.99% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 9.86% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 18.69% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -102.03% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.27% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -7.01% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -3.15% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.22% |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | 39.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.06% |
| Dec 31, 2025 | 84.84% |
| Dec 31, 2024 | 88.13% |
| Sep 30, 2024 | 57.70% |
| Dec 31, 2022 | -1,037.29% |
| Sep 30, 2022 | -224.51% |
| Mar 31, 2022 | -389.60% |
| Dec 31, 2021 | -393.88% |
| Sep 30, 2021 | 36.45% |
| Jun 30, 2021 | -35.26% |
| Mar 31, 2021 | -50.42% |
| Dec 31, 2018 | 52.63% |
| Sep 30, 2018 | -200.01% |
| Mar 31, 2018 | 42.45% |
| Dec 31, 2017 | 50.07% |
| Sep 30, 2017 | -118.48% |
| Dec 31, 2015 | -439.11% |
| Sep 30, 2015 | 24.46% |
| Mar 31, 2015 | 13.96% |
| Dec 31, 2014 | -9.02% |